Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHA Scientific Sessions In Brief

This article was originally published in The Tan Sheet

Executive Summary

Aspirin and women: Aspirin "can significantly decrease death rates in postmenopausal women with cardiovascular disease," according to a study presented at the American Heart Association's annual Scientific Sessions in Dallas, Tex., Nov. 13-15. Jeffrey Berger, MD, Duke University Medical College, et al., evaluated 8,928 women age 50-79 with stable CVD from the multi-center Women's Health Initiative Observational Study. Aspirin use was reported by 46% of the population: 30% took 81 mg daily and 70% took 325 mg daily. During 6.5 years of follow-up, both doses were associated with a 17% reduction in all-cause mortality and a 25% lower death rate from all cardiovascular diseases when compared to non-aspirin users...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098860

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel